Session » Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations

Date: Monday, November 9, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1278

An Underlying Diagnosis of Osteoarthritis Is Associated with Better Outcomes after Total Hip Arthroplasty Than Avascular Necrosis of Bone

9:00AM-11:00AM: Abstract Number: 1284

Burden of Illness Associated with Non-Radiographic Axial Spondyloarthritis: A European Real World Database Analysis from the Clinical and Healthcare System Perspective

9:00AM-11:00AM: Abstract Number: 1290

Burden of Rheumatoid Arthritis in the US Elderly Population: Comorbidities, Healthcare Resource Utilization, and Cost

9:00AM-11:00AM: Abstract Number: 1280

Comparison of Health Service Utilization Costs Between Aboriginal and Non-Aboriginal Patients with Rheumatoid Arthritis Requiring Biologic Therapy

9:00AM-11:00AM: Abstract Number: 1271

Cost Savings and Interest in Pediatric Rheumatology Telemedicine Visits

9:00AM-11:00AM: Abstract Number: 1267

Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF

9:00AM-11:00AM: Abstract Number: 1288

Dual Care Utilization in Patients Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry

9:00AM-11:00AM: Abstract Number: 1274

Factors That Impact Job Selection in Pediatric Rheumatology

9:00AM-11:00AM: Abstract Number: 1289

Healthcare Utilization Differences According to Sex Among Children and Adults in Medicaid with Incident Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 1287

Impact of Participation in Adalimumab Patient Support Program (PSP) on Clinical Outcomes and Predictors of PSP Utilization Among Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1276

Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey

9:00AM-11:00AM: Abstract Number: 1270

Low Socioeconomic Status As a Predictor of Long-Term Direct Medical Costs Following Diagnosis of Granulomatosus with Polyangiitis: A General Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 1285

Markers of Non-Compliance with ASAS/EULAR Management Recommendations Among Early Spa Patients: Evidence over 3 Years in the DESIR Cohort

9:00AM-11:00AM: Abstract Number: 1269

Measuring the Rheumatologist Workforce in Canada: Preliminary Results of the Stand up and be Counted Survey

9:00AM-11:00AM: Abstract Number: 1275

Pediatric Rheumatology Work Force and Patients Status in Latin America. a Snap Shot Web Based Survey

9:00AM-11:00AM: Abstract Number: 1282

Persistence with Osteoporosis Therapies in Postmenopausal Women in a Large US National Health Plan

9:00AM-11:00AM: Abstract Number: 1286

Persistent Individual and Neighborhood Poverty Are Independent Risk Factors for Accumulated Lupus Damage

9:00AM-11:00AM: Abstract Number: 1279

Racial Variation in Total Knee Replacement in a Diverse Community-Based Clinical Trial

9:00AM-11:00AM: Abstract Number: 1281

Reduction in Rural-Urban Disparity in Discharge Disposition to Home after Total Knee Arthroplasty in the U.S

9:00AM-11:00AM: Abstract Number: 1266

Rheumatologic Diagnoses, Characteristics and Needs of Somali Patients Referred to a Rheumatology Clinic Serving the Somali Population

9:00AM-11:00AM: Abstract Number: 1283

The Burden of Non-Radiographic Axial Spondyloarthritis from the Employer Perspective: A Real World European Study

9:00AM-11:00AM: Abstract Number: 1291

The Pediatric Rheumatology Workforce in 2015: A Survey of Pediatric Rheumatologists

9:00AM-11:00AM: Abstract Number: 1273

Uptake of the First Biosimilar Infliximab Since Its Approval in South Korea

9:00AM-11:00AM: Abstract Number: 1277

US Adult Rheumatologists Perspective on the Transition Process for Young Adults with Rheumatic Conditions

9:00AM-11:00AM: Abstract Number: 1272

Utilization of Ambulatory Physician Encounters, Emergency Room Visits and Hospitalizations By SLE Patients: A 13 Year Population Health Study

9:00AM-11:00AM: Abstract Number: 1268

Utilization of Viscosupplementation: 2011 – 2013

9:00AM-11:00AM: Abstract Number: 1292

What Is the Effect of TNF Inhibitors on Employment Status in Rheumatoid Arthritis Patients and What Are the Predictors of Progression to Unemployment?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].